Becton Dickinson (BDX) Financial Analysis & Valuation | Quarter Chart
Becton Dickinson (BDX)
BDXPrice: $150
Fair Value: 🔒
🔒score
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company... more
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laborator... more
Description
Shares
| Market Cap | $54.34B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | US | CEO | Thomas E. Polen Jr. |
| IPO Date | 1973-02-21 | CAGR | 0.08% |
| Employees | 70,000 | Website | www.bd.com |
| Div. Yield | 2.34% | Payout Ratio | 1.04% |
| Buy Back Yield | 0.46% | Total Yield | 2.8% |
BDX chart loading...
Fundamentals
Technicals
| Enterprise Value | $60.59B | P/E Ratio | 23.68 |
| Forward P/E | 10.75 | PEG Ratio | — |
| P/S Ratio | 2.54 | P/B Ratio | 1.74 |
| P/CF Ratio | 10.79 | P/FCF Ratio | 17.3 |
| EPS | $6.11 | EPS Growth 1Y | -24.62% |
| EPS Growth 3Y | -25.89% | EPS Growth 5Y | -29.72% |
| Revenue Growth 1Y | 2.39% | Gross Margin | 0.46% |
| Operating Margin | 0.11% | Profit Margin | 0.05% |
| ROE | 0.05% | ROA | 0.02% |
| ROCE | 0.05% | Current Ratio | 0.94 |
| Quick Ratio | 0.55 | Cash Ratio | 0.1 |
| Debt/Equity | 0.72 | Interest Coverage | 4.03 |
| Altman Z Score | 2.28 | Piotroski Score | 8 |